Chantada-Vázquez, M.d.P.; Conde-Amboage, M.; Graña-López, L.; Vázquez-Estévez, S.; Bravo, S.B.; Núñez, C.
Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancers 2022, 14, 1087.
https://doi.org/10.3390/cancers14041087
AMA Style
Chantada-Vázquez MdP, Conde-Amboage M, Graña-López L, Vázquez-Estévez S, Bravo SB, Núñez C.
Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancers. 2022; 14(4):1087.
https://doi.org/10.3390/cancers14041087
Chicago/Turabian Style
Chantada-Vázquez, MarÃa del Pilar, Mercedes Conde-Amboage, LucÃa Graña-López, Sergio Vázquez-Estévez, Susana B. Bravo, and Cristina Núñez.
2022. "Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer" Cancers 14, no. 4: 1087.
https://doi.org/10.3390/cancers14041087
APA Style
Chantada-Vázquez, M. d. P., Conde-Amboage, M., Graña-López, L., Vázquez-Estévez, S., Bravo, S. B., & Núñez, C.
(2022). Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancers, 14(4), 1087.
https://doi.org/10.3390/cancers14041087